JAC Advance Access originally published online on November 28, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 184-185
© 2003 The British Society for Antimicrobial Chemotherapy
Correspondence |
The presence of ermB in Streptococcus pneumoniae has no influence on AZD2563 MIC values
Eijkman-Winkler Center, UMCU, Room G04.614, PO Box 85500, 3508 GA Utrecht, The Netherlands
Keywords: AZD2563, ermB, pneumococcus
| The first 10% of the full text of this article appears below. |
Sir,
The treatment of Streptococcus pneumoniae infections is increasingly threatened by the emergence of penicillin- and macrolide-resistant strains. Macrolide-resistant or not fully susceptible S. pneumoniae isolates often contain either ermB, mefE or both determinants. In some cases a mutant ribosomal protein has been detected. Methylation of ribosomal RNA by the ermB
Acknowledgements